Literature DB >> 11910899

Epitope spreading in immune-mediated diseases: implications for immunotherapy.

Carol L Vanderlugt1, Stephen D Miller.   

Abstract

Evidence continues to accumulate supporting the hypothesis that tissue damage during an immune response can lead to the priming of self-reactive T and/or B lymphocytes, regardless of the specificity of the initial insult. This review will focus primarily on epitope spreading at the T-cell level. Understanding the cellular and molecular basis of epitope spreading in various chronic immune-mediated human diseases and their animal models is crucial to understanding the pathogenesis of these diseases and to the ultimate goal of designing antigen-specific treatments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11910899     DOI: 10.1038/nri724

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  279 in total

1.  Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.

Authors:  Maureen H Richards; Meghann Teague Getts; Joseph R Podojil; Young-Hee Jin; Byung S Kim; Stephen D Miller
Journal:  J Autoimmun       Date:  2011-01-26       Impact factor: 7.094

2.  Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance.

Authors:  Brian W Busser; Brigette S Adair; Jan Erikson; Terri M Laufer
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

3.  Mapping of the immunodominant T cell epitopes of the protein topoisomerase I.

Authors:  S Veeraraghavan; E A Renzoni; H Jeal; M Jones; J Hammer; A U Wells; C M Black; K I Welsh; R M du Bois
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

Review 4.  Management of secondary-progressive multiple sclerosis.

Authors:  Gavin Giovannoni
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 5.  Mechanisms and models of immune tolerance breakdown in the ovary.

Authors:  Mickie H Cheng; Lawrence M Nelson
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

6.  Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology.

Authors:  Daniel Larocque; Nicholas S R Sanderson; Josée Bergeron; James F Curtin; Joe Girton; Mia Wibowo; Niyati Bondale; Kurt M Kroeger; Jieping Yang; Liliana M Lacayo; Kevin C Reyes; Catherine Farrokhi; Robert N Pechnick; Maria G Castro; Pedro R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

Review 7.  Have we overestimated the benefit of human(ized) antibodies?

Authors:  Daniel R Getts; Meghann T Getts; Derrick P McCarthy; Emily M L Chastain; Stephen D Miller
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

8.  Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.

Authors:  Suchitra Prasad; Adam P Kohm; Jeffrey S McMahon; Xunrong Luo; Stephen D Miller
Journal:  J Autoimmun       Date:  2012-05-28       Impact factor: 7.094

Review 9.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

10.  Retinal S-antigen Th1 cell epitope mapping in patients with Behcet's disease.

Authors:  Changlin Zhao; Peizeng Yang; Hao He; Xiaomin Lin; Liping Du; Hongyan Zhou; Aize Kijlstra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-29       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.